[{"AccountsPayableCurrent_0_Q2_USD":13762000.0,"OtherAssetsNoncurrent_0_Q2_USD":21200000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":12000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":12000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":235000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":843000.0,"OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_1_Q2_USD":52000.0,"OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_2_Q2_USD":184000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":22028000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1_Q2_USD":3000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":247000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":855000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":6535000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":234000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-2966000.0,"PaymentsForTenantImprovements_2_Q2_USD":67000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":14438000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_2_Q2_USD":3000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":145255000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":44201000.0,"OperatingIncomeLoss_2_Q2_USD":-91889000.0,"InvestmentIncomeInterest_1_Q2_USD":50000.0,"InvestmentIncomeInterest_2_Q2_USD":215000.0,"Liabilities_0_Q2_USD":572982000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":786892000.0,"LiabilitiesCurrent_0_Q2_USD":111993000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":31550000.0,"LongTermDebt_0_Q2_USD":390434000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":7106000.0,"MarketableSecuritiesCurrent_0_Q2_USD":206530000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":112278000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-108277000.0,"NetIncomeLoss_1_Q2_USD":-51225000.0,"NetIncomeLoss_2_Q2_USD":-116889000.0,"OperatingExpenses_1_Q2_USD":107867000.0,"OperatingExpenses_2_Q2_USD":220785000.0,"OperatingIncomeLoss_1_Q2_USD":-38834000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":11064000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1234000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":24176000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":258767000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":14800000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":15000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":13586000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":10.8,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":7.29,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":13.21,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":13.04,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":11.02,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":18.54,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":945000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2_Q2_USD":21000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":6661000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":2500000.0,"WarrantsAndRightsOutstanding_0_Q2_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":265384865.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":266398516.0,"StockholdersEquity_0_Q2_USD":213910000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":14962000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":15100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2453000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":6661000.0,"ProceedsFromWarrantExercises_2_Q2_USD":19230000.0,"ProfitLoss_2_Q2_USD":-116889000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":42365000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":63003000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":127120000.0,"RestrictedCashAndCashEquivalents_0_Q2_USD":3250000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-2162351000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":77413000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":143815000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":42276000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":89002000.0,"ShareBasedCompensation_2_Q2_USD":32090000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":9074000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":9.34,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":54000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":524000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":11306000.0,"InventoryValuationReserves_0_Q2_USD":200000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":7619000.0,"InventoryNet_0_Q2_USD":24086000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":4000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":206505000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":206530000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":1492000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":27317000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":19800000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":7517000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":29000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":191000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":176538000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":179788000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":13626000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"CommonStockSharesIssued_0_Q2_shares":266532536.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":176538000.0,"AssetsFairValueDisclosure_0_Q2_USD":210711000.0,"AssetsCurrent_0_Q2_USD":480502000.0,"Assets_0_Q2_USD":786892000.0,"AccountsReceivableNetCurrent_0_Q2_USD":49172000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":71325000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":17410000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q2_USD":-173000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q2_USD":9255000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":2364494000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":244000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":14438000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":32090000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":11736000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":11736000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":32090000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":100000.0,"AmortizationOfDebtDiscountPremium_1_Q2_USD":383000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":720000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":1200000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":22832000.0,"CommonStockSharesOutstanding_0_Q2_shares":266532536.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":265384865.0,"CommonStockValue_0_Q2_USD":2685000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-116034000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-46700000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-110782000.0,"IncomeTaxesPaidNet_2_Q2_USD":4526000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":4525000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":6107000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-28485000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":3127000.0,"GrossProfit_2_Q2_USD":128896000.0,"IncreaseDecreaseInInventories_2_Q2_USD":4445000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":23000000.0,"InterestExpense_1_Q2_USD":8150000.0,"InterestExpense_2_Q2_USD":16142000.0,"InterestExpenseDebtExcludingAmortization_1_Q2_USD":7604000.0,"InterestExpenseDebtExcludingAmortization_2_Q2_USD":15125000.0,"InterestPaidNet_2_Q2_USD":15109000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":5161000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-5265000.0,"GrossProfit_1_Q2_USD":69033000.0,"Goodwill_0_Q2_USD":197797000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":389000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":8380000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":14919000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":17200000.0,"DebtSecuritiesRealizedGainLoss_2_Q2_USD":0.0,"DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_0_Q2_USD":4233000.0,"DeferredCreditsAndOtherLiabilitiesNoncurrent_0_Q2_USD":7406000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":4896000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":1567000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":3171000.0,"EarningsPerShareBasic_2_Q2_USD":-0.44,"EarningsPerShareBasic_1_Q2_USD":-0.19,"EarningsPerShareDiluted_1_Q2_USD":-0.19,"EarningsPerShareDiluted_2_Q2_USD":-0.44,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-1439000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q2_USD":-1021000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_Q2_USD":-1492000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q2_USD":27317000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-50978000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":266398516.0,"Ticker":"FOLD","CIK":"1178879","name":"AMICUS THERAPEUTICS, INC.","OfficialName":"Amicus Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2296240629.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]